Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP)
Strategy of Systolic Blood Pressure Intervention in the Elderly Hypertensive Patients: A Prospective Randomized Open-Label Blinded-Endpoint Trial
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
Listed as NCT03015311, this NA trial focuses on Primary Hypertension and remains ongoing. Sponsored by Chinese Academy of Medical Sciences, Fuwai Hospital, it has been updated 11 times since 2017, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Aug 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Sep 2021 — Aug 2023 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
-
Aug 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Aug 2019 [monthly]
Active Not Recruiting NA
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2017 — Apr 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2017 [monthly]
Recruiting NA
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese Academy of Medical Sciences, Fuwai Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Baotou, China , Beijing, China , Benxi, China , Chengdu, China , Dalian, China , Guangzhou, China , Harbin, China , Huizhou, China , Jinan, China , Jining, China and 21 more locations